OPTI-FREE RepleniSH
Showing 1 - 25 of >10,000
Refractive Errors Trial in Maitland, Memphis, Wichita Falls (LID021201 contact lenses, OPTI-FREE multipurpose solution)
Completed
- Refractive Errors
- LID021201 contact lenses
- OPTI-FREE multipurpose solution
-
Maitland, Florida
- +2 more
Mar 8, 2022
Refractive Errors Trial in Orlando, Bloomington, Powell (Lehfilcon A contact lenses, Multipurpose disinfection solution)
Completed
- Refractive Errors
- Lehfilcon A contact lenses
- Multipurpose disinfection solution
-
Orlando, Florida
- +2 more
Dec 15, 2021
Refractive Errors Trial in Maitland, Bloomington, Memphis (Lehfilcon A contact lenses, Comfilcon A contact lenses, Multi-purpose
Completed
- Refractive Errors
- Lehfilcon A contact lenses
- +2 more
-
Maitland, Florida
- +2 more
Apr 22, 2021
Myopia Trial in Hsinchu (41% Silicone Hydrogel Soft Contact Lenses(SHSCL), ACUVUE® VITA™ (senofilcon C) Brand (Soft) Contact
Recruiting
- Myopia
- 41% Silicone Hydrogel Soft Contact Lenses(SHSCL)
- +3 more
-
Hsinchu, TaiwanApexLens Co., Ltd.
Feb 23, 2021
Refractive Errors, Ametropia Trial in Johns Creek (Contact lens with investigational coating 1, Balafilcon A contact lens,
Completed
- Refractive Errors
- Ametropia
- Contact lens with investigational coating 1
- +3 more
-
Johns Creek, GeorgiaAlcon Investigative Site
Feb 5, 2020
Refractive Errors Trial in Maitland (LID018869+RepleniSH, LID018869+Biotrue, Biofinity+RepleniSH)
Completed
- Refractive Errors
- LID018869+RepleniSH
- +3 more
-
Maitland, FloridaAlcon Investigator 6565
May 3, 2022
Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- +4 more
- Olaparib
- +4 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 13, 2023
Hyperoxia Trial (FiO2 titration using electronic alert system)
Not yet recruiting
- Hyperoxia
- FiO2 titration using electronic alert system
- (no location specified)
Jun 20, 2023
Visual Acuity, Slit Lamp Biomicroscopy (Corneal Staining Assessment) Trial in United States (Opti-Free : RevitaLens / Clear Care
Completed
- Visual Acuity, Slit Lamp Biomicroscopy (Corneal Staining Assessment)
- Opti-Free : RevitaLens / Clear Care : RevitaLens
- +7 more
-
Anaheim, California
- +4 more
Oct 1, 2019
Malignant Tumor, Surgical Procedure, Unspecified, Health Care Provider Trial in United States (Best Practice, Informational
Recruiting
- Malignant Neoplasm
- +3 more
- Best Practice
- +3 more
-
Newark, Delaware
- +43 more
Aug 2, 2022
Pregnancy, Living in an Isolated Area Trial in Clermont-Ferrand (Home visitation)
Recruiting
- Pregnancy
- Living in an Isolated Area
- Home visitation
-
Clermont-Ferrand, Aura, FranceCHU Clermont-Ferrand
Dec 20, 2022
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Not yet recruiting
- Hidradenitis Suppurativa
- Mental health
-
Birmingham, AlabamaWhitaker Clinic
Aug 16, 2022
Bloating Trial in Foothill Ranch, Orlando, London (OPTI-BIOME™ Bacillus subtilis MB40, Placebo)
Completed
- Bloating
- OPTI-BIOME™ Bacillus subtilis MB40
- Placebo
-
Foothill Ranch, California
- +2 more
Oct 22, 2021
Sensation and Satisfaction in Cancer and Transgender Mastectomy
Recruiting
- Sensation Disorders
- +8 more
- Sensory testing
-
Boston, Massachusetts
- +1 more
Oct 16, 2023
Blood Loss Anemia Trial in Linz (Ferric carboxymaltose, Crystalloid)
Recruiting
- Blood Loss Anemia
- Ferric carboxymaltose
- Crystalloid
-
Linz, AustriaUniversitätsklinik für Anästhesie und Intensivmedizin
Mar 30, 2022
Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection Trial in Worcester (Fecal Microbiota
Recruiting
- Clostridium Difficile Infection Recurrence
- Clostridium Difficile Infection
- Fecal Microbiota Transplantation
-
Worcester, MassachusettsUMass Memorial Medical Center
Dec 19, 2022
Pediatric Kidney Transplant Recipients Trial in Paris (Bayesian based dose adjustment of enoxaparin, Usual dose adjustment of
Not yet recruiting
- Pediatric Kidney Transplant Recipients
- Bayesian based dose adjustment of enoxaparin
- Usual dose adjustment of enoxaparin
-
Paris, Ile-de-France, FranceHôpital Necker - Enfants malades
Jan 23, 2023
Skin Condition Trial in Cheras, Petaling Jaya (Rice ceramide supplementation)
Completed
- Skin Condition
- Rice ceramide supplementation
-
Cheras, Kuala Lumpur, Malaysia
- +1 more
Sep 27, 2022
Vaccine Reaction Trial in Bandung (Gardasil, PharmaJet Stratis® Needle-Free Injection System, PharmaJet Tropis® Needle-Free
Not yet recruiting
- Vaccine Reaction
- Gardasil
- +2 more
-
Bandung, IndonesiaUniversitas Padjadjaran
Nov 16, 2023
Thoracic Injuries, Non-invasive Ventilation Trial (other, procedure, biological)
Not yet recruiting
- Thoracic Injuries
- Non-invasive Ventilation
- Lung Ultrasound for PEEP setting
- +3 more
- (no location specified)
Oct 2, 2023
OPTI-Prem: Optimising Neonatal Service Provision for Preterm
Active, not recruiting
- Neonatal Diseases and Abnormalities
-
Wolverhampton, United KingdomThe Royal Wolverhampton NHS Trust
Aug 16, 2022
Sedation and Analgesia Monitoring Trial in France (anesthesia guided by sedation and analgesia monitoring, anesthesia performed
Not yet recruiting
- Sedation and Analgesia Monitoring
- anesthesia guided by sedation and analgesia monitoring
- anesthesia performed according only to the clinical judgment of the anesthetist as usual practice
-
Amiens, France
- +13 more
Jun 5, 2023
Dietary Behaviour Trial in Bournemouth (Dietary Advice)
Not yet recruiting
- Dietary Behaviour
- Dietary Advice
-
Bournemouth, US And Canada Only, United KingdomBournemouth University
Jul 10, 2023
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Alkmaar, Netherlands
- +27 more
Jun 27, 2023